Although originally focused more on providers and health tech, the US conference HLTH has been steadily widening its scope and now hosts a wide variety of healthcare stakeholders.
Roche has launched what it says is a first-of-its-kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliv
Roche has said it will pay $1.8 billion for molecular testing company GenMark, boosting the Swiss company’s diagnostic capabilities and adding rapid COVID tests to its pandemic arsenal.
For episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Ireland at Roche Diagnostics, about the pressure COVID-19 has put on healthcare systems.
The UK government has backed five new centres for artificial intelligence (AI) in health, focusing on areas including pathology, radiology and imaging.
Biogen has scaled back its ambitions for Denali-partnered Parkinson’s disease candidate BIIB122, abandoning a complex and likely costly phase 3 trial that isn’t due to com
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas